Compliance and patching and atropine amblyopia treatments
- PMID: 25743080
- DOI: 10.1016/j.visres.2015.02.012
Compliance and patching and atropine amblyopia treatments
Abstract
In the past 20 years, there has been a great advancement in knowledge pertaining to compliance with amblyopia treatments. The occlusion dose monitor introduced quantitative monitoring methods in patching, which sparked our initial understanding of the dose-response relationship for patching amblyopia treatment. This review focuses on current compliance knowledge and the impact it has on patching and atropine amblyopia treatment.
Keywords: Amblyopia; Atropine penalization; Children; Compliance; Occlusion; Patching.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Comment in
-
"Compliance and patching and atropine amblyopia treatments"--Reply to Letter to the Editor.Vision Res. 2015 Oct;115(Pt A):153-4. doi: 10.1016/j.visres.2015.08.003. Epub 2015 Aug 19. Vision Res. 2015. PMID: 26277264 No abstract available.
-
Concerning manuscript "Compliance and patching and atropine amblyopia treatments" by Jingyun Wang.Vision Res. 2015 Oct;115(Pt A):151-2. doi: 10.1016/j.visres.2015.08.002. Epub 2015 Sep 1. Vision Res. 2015. PMID: 26319949 No abstract available.
Similar articles
-
Atropine penalization for "rescuing" patching failures.Arch Ophthalmol. 2009 Feb;127(2):220-1. doi: 10.1001/archophthalmol.2008.560. Arch Ophthalmol. 2009. PMID: 19204246 No abstract available.
-
Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.J AAPOS. 2008 Oct;12(5):493-7. doi: 10.1016/j.jaapos.2008.03.006. Epub 2008 Jun 5. J AAPOS. 2008. PMID: 18534880 Clinical Trial.
-
"Compliance and patching and atropine amblyopia treatments"--Reply to Letter to the Editor.Vision Res. 2015 Oct;115(Pt A):153-4. doi: 10.1016/j.visres.2015.08.003. Epub 2015 Aug 19. Vision Res. 2015. PMID: 26277264 No abstract available.
-
The treatment of amblyopia: current practice and emerging trends.Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1061-1078. doi: 10.1007/s00417-019-04254-w. Epub 2019 Jan 31. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30706134 Review.
-
Amblyopia.Lancet. 2006 Apr 22;367(9519):1343-51. doi: 10.1016/S0140-6736(06)68581-4. Lancet. 2006. PMID: 16631913 Review.
Cited by
-
Contribution of Short-Time Occlusion of the Amblyopic Eye to a Passive Dichoptic Video Treatment for Amblyopia beyond the Critical Period.Neural Plast. 2019 Aug 28;2019:6208414. doi: 10.1155/2019/6208414. eCollection 2019. Neural Plast. 2019. PMID: 31558900 Free PMC article.
-
[Amblyopia-Basic principles and current diagnostic and therapeutic standards].Ophthalmologe. 2019 Apr;116(4):391-404. doi: 10.1007/s00347-019-0876-4. Ophthalmologe. 2019. PMID: 30888470 German.
-
Randomised trial of three treatments for amblyopia: Vision therapy and patching, perceptual learning and patching alone.Ophthalmic Physiol Opt. 2025 Jan;45(1):31-42. doi: 10.1111/opo.13395. Epub 2024 Oct 12. Ophthalmic Physiol Opt. 2025. PMID: 39396111 Free PMC article. Clinical Trial.
-
A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia.J AAPOS. 2016 Aug;20(4):326-31. doi: 10.1016/j.jaapos.2016.05.014. Epub 2016 Jul 12. J AAPOS. 2016. PMID: 27418249 Free PMC article. Clinical Trial.
-
Characterization, passive and active treatment in strabismic amblyopia: a narrative review.Int J Ophthalmol. 2020 Jul 18;13(7):1132-1147. doi: 10.18240/ijo.2020.07.18. eCollection 2020. Int J Ophthalmol. 2020. PMID: 32685403 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous